COVID-19 vaccine
-
April 13, 2022
Additional COVID vaccine helps protect transplant patients
Additional booster doses of vaccine against COVID-19 are particularly important for those who are immunosuppressed, namely those who have had solid organ transplants, a new study shows. -
April 13, 2022
Volunteering for vaccine research a family affair
-
April 7, 2022
Study explores parents’ reluctance to flu, COVID vaccines for children
Vanderbilt research found parents who are reluctant to vaccinate their children against the flu are more than five times as likely to decline the COVID-19 vaccine for their children. -
March 7, 2022
Teen shares his battle with MIS-C following COVID-19 infection
Reeyan Ahmed is among the patients treated at Monroe Carell Jr. Children's Hospital at Vanderbilt who developed MIS-C following COVID-19 infection. -
March 3, 2022
COVID-19: two years of challenges, lessons, victories
Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee. -
February 24, 2022
MIS-C diagnosis rare in vaccinated children with no previous COVID-19 diagnosis
A Vanderbilt study found that children who received the COVID-19 vaccine who had not previously been diagnosed with COVID infection are unlikely to be diagnosed with multisystem inflammatory syndrome in children (MIS-C). -
February 9, 2022
Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization
Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.